12 research outputs found

    Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients

    Get PDF
    Pleiotrophin is a heparin-binding growth factor involved in the differentiation and proliferation of neuronal tissue during embryogenesis, and also secreted by melanoma and breast carcinoma cells. Pleiotrophin exhibits mitogenic and angiogenic properties and has been shown to influence the vascular supply, expansion and metastasis of tumour cells. Our aim was to study the serum and plasma concentrations of pleiotrophin and the classical angiogenic growth factor vascular endothelial growth factor. Using a specific ELISA-test we studied patients with small cell lung cancer (n=63), and patients with non-small cell lung cancer (n=22) in comparison to healthy control subjects (n=41). In most of the lung cancer patients (81%), we found serum levels of pleiotrophin above those of control subjects (P<0.001). Of the 63 small cell lung cancer patients in the study pleiotrophin serum levels were elevated in 55 cases (87%) and in 14 cases (63%) of the 22 non-small cell lung cancer patients. Pleiotrophin mean serum concentrations were 10.8-fold higher in the tumour patient group as compared to the control group (P<0.001). Furthermore, pleiotrophin serum levels correlated positively with the stage of disease and inversely with the response to therapy. Plasma vascular endothelial growth factor concentrations were elevated in only in 28.6% of small cell lung cancer and 45.5% of non-small cell lung cancer patients by an average of 2.3-fold. Quite strikingly, there was no apparent correlation between the plasma vascular endothelial growth factor concentration and the stage of disease. Our study suggests that pleiotrophin may be an early indicator of lung cancer and might be of use in monitoring the efficacy of therapy, which needs to be confirmed by larger studies

    Horticultural Science’s Role in Meeting the Need of Urban Populations

    No full text

    Everyday local nearby healthy childhoodnature settings as sites for promoting Children's health and well-being

    No full text
    In this chapter, we highlight the central role that healthy, vibrant, and functioning “everyday, local, and nearby” childhoodnature ecosystems can play in both keeping children healthy and in helping them to understand the relationship between ecosystem health and their own health. By understanding these interconnections, children can learn that they are not separate from or superior to nature. Rather, these settings become sites where children can refresh and reimagine understandings of nature and their relationships as, within, of, and to nature. Healthy settings are, we believe, a foundation for healthy children. A focus on health is particularly timely for two reasons. First, there are mounting international concerns about children’ health – be it around issues of physical activity, mental illness, social resiliency and belonging, overweight and obesity, and spiritual grounding. But it is not only children’s health that is of concern: there are deep and mounting international concerns about the health of ecological systems, be it around issues of global warming, acid rain, species loss, air pollution, urban sprawl, waste disposal, ozone layer depletion, and water pollution. This Chapter is framed around the World Health Organization’s definition of health and explores the ways in which local nearby natural childhoodnature settings can promote physical, mental, social, and spiritual health and well-being of children. To illustrate these concepts in action, we profile a case study from our research in Australia. This chapter concludes with a discussion on the ways that healthy childhoodnature settings can unite, inform, and support the interests of educators, environmentalists, and children’s health advocates who have an interest in the health of children and ecosystems

    Transforming Growth Factor-β and Breast Cancer

    No full text
    corecore